Association between estrogen receptora gene (ESR1) PvuII (T/C) and XbaI (A/G) polymorphisms and premature ovarian failure risk: evidence from a meta-analysis

Background and aims Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a ( ESR1 ) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and...

Full description

Saved in:
Bibliographic Details
Published inJournal of assisted reproduction and genetics Vol. 32; no. 2; pp. 297 - 304
Main Authors He, Meirong, Shu, Jingcheng, Huang, Xing, Tang, Hui
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.02.2015
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background and aims Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a ( ESR1 ) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: T.C and XbaI-rs9340799: A.G) and POF. Methods A comprehensive search was conducted to identify all studies on the association of ESR1 gene polymorphisms with POF up to August 2014. Pooled odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated using fixed-or random-effects model in the meta-analysis. Results Three studies covering 1396 subjects were identified. Pooled data showed significant association between ESR1 gene PvuII polymorphism and risk of POF: [allele model: Cvs. T, OR = 0.735, 95%CI: 0.624 ~ 0.865, p  = 0.001; co-dominant models: CCvs.TT, OR = 0.540, 95%CI: 0.382 ~ 0.764, p  = 0.001, CTvs.TT, OR = 0.735, 95%CI: 0.555 ~ 0.972, p  = 0.031; dominant model: CT + CCvs.TT, OR = 0.618, 95%CI: 0.396 ~ 0.966, p  = 0.035; recessive model: CCvs.TT + CT, OR = 0.659, 95%CI: 0.502 ~ 0.864, p  = 0.003]. Subgroup analyses showed a significant association in all models in Asian population, but no significant association in any model in European population. For the XbaI polymorphism, overall, no significant association was observed under any genetic models. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population. Conclusion The present meta-analysis suggests that ESR1 gene PvuII polymorphism is significantly associated with an increased risk of POF. And ESR1 gene XbaI polymorphism is not association with risk of POF overall. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population. Further large and well-designed studies are needed to confirm the association.
AbstractList Background and aims: Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a (ESR1) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: T.C and XbaI-rs9340799: A.G) and POF. Methods: A comprehensive search was conducted to identify all studies on the association of ESR1 gene polymorphisms with POF up to August 2014. Pooled odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated using fixed-or random-effects model in the meta-analysis. Results: Three studies covering 1396 subjects were identified. Pooled data showed significant association between ESR1 gene PvuII polymorphism and risk of POF: [allele model: Cvs. T, OR=0.735, 95%CI: 0.624~0.865, p=0.001; co-dominant models: CCvs.TT, OR=0.540, 95%CI: 0.382~0.764, p=0.001, CTvs.TT, OR=0.735, 95%CI: 0.555~0.972, p=0.031; dominant model: CT+CCvs.TT, OR=0.618, 95%CI: 0.396~0.966, p=0.035; recessive model: CCvs.TT+CT, OR=0.659, 95%CI: 0.502~0.864, p=0.003]. Subgroup analyses showed a significant association in all models in Asian population, but no significant association in any model in European population. For the XbaI polymorphism, overall, no significant association was observed under any genetic models. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population. Conclusion: The present meta-analysis suggests that ESR1gene PvuII polymorphism is significantly associated with an increased risk of POF. And ESR1gene XbaI polymorphism is not association with risk of POF overall. However, under dominant model, ESR1gene XbaI polymorphism is significantly association with risk of POF in Asian population. Further large and well-designed studies are needed to confirm the association.
Background and aims Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a ( ESR1 ) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: T.C and XbaI-rs9340799: A.G) and POF. Methods A comprehensive search was conducted to identify all studies on the association of ESR1 gene polymorphisms with POF up to August 2014. Pooled odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated using fixed-or random-effects model in the meta-analysis. Results Three studies covering 1396 subjects were identified. Pooled data showed significant association between ESR1 gene PvuII polymorphism and risk of POF: [allele model: Cvs. T, OR = 0.735, 95%CI: 0.624 ~ 0.865, p  = 0.001; co-dominant models: CCvs.TT, OR = 0.540, 95%CI: 0.382 ~ 0.764, p  = 0.001, CTvs.TT, OR = 0.735, 95%CI: 0.555 ~ 0.972, p  = 0.031; dominant model: CT + CCvs.TT, OR = 0.618, 95%CI: 0.396 ~ 0.966, p  = 0.035; recessive model: CCvs.TT + CT, OR = 0.659, 95%CI: 0.502 ~ 0.864, p  = 0.003]. Subgroup analyses showed a significant association in all models in Asian population, but no significant association in any model in European population. For the XbaI polymorphism, overall, no significant association was observed under any genetic models. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population. Conclusion The present meta-analysis suggests that ESR1 gene PvuII polymorphism is significantly associated with an increased risk of POF. And ESR1 gene XbaI polymorphism is not association with risk of POF overall. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population. Further large and well-designed studies are needed to confirm the association.
Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a (ESR1) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: T.C and XbaI-rs9340799: A.G) and POF. A comprehensive search was conducted to identify all studies on the association of ESR1 gene polymorphisms with POF up to August 2014. Pooled odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated using fixed-or random-effects model in the meta-analysis. Three studies covering 1396 subjects were identified. Pooled data showed significant association between ESR1 gene PvuII polymorphism and risk of POF: [allele model: Cvs. T, OR = 0.735, 95%CI: 0.624 ~ 0.865, p = 0.001; co-dominant models: CCvs.TT, OR = 0.540, 95%CI: 0.382 ~ 0.764, p = 0.001, CTvs.TT, OR = 0.735, 95%CI: 0.555 ~ 0.972, p = 0.031; dominant model: CT + CCvs.TT, OR = 0.618, 95%CI: 0.396 ~ 0.966, p = 0.035; recessive model: CCvs.TT + CT, OR = 0.659, 95%CI: 0.502 ~ 0.864, p = 0.003]. Subgroup analyses showed a significant association in all models in Asian population, but no significant association in any model in European population. For the XbaI polymorphism, overall, no significant association was observed under any genetic models. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population. The present meta-analysis suggests that ESR1gene PvuII polymorphism is significantly associated with an increased risk of POF. And ESR1gene XbaI polymorphism is not association with risk of POF overall. However, under dominant model, ESR1gene XbaI polymorphism is significantly association with risk of POF in Asian population. Further large and well-designed studies are needed to confirm the association.
Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a (ESR1) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: T.C and XbaI-rs9340799: A.G) and POF. A comprehensive search was conducted to identify all studies on the association of ESR1 gene polymorphisms with POF up to August 2014. Pooled odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated using fixed-or random-effects model in the meta-analysis. Three studies covering 1396 subjects were identified. Pooled data showed significant association between ESR1 gene PvuII polymorphism and risk of POF: [allele model: Cvs. T, OR=0.735, 95%CI: 0.624~0.865, p=0.001; co-dominant models: CCvs.TT, OR=0.540, 95%CI: 0.382~0.764, p=0.001, CTvs.TT, OR=0.735, 95%CI: 0.555~0.972, p=0.031; dominant model: CT+CCvs.TT, OR=0.618, 95%CI: 0.396~0.966, p=0.035; recessive model: CCvs.TT+CT, OR=0.659, 95%CI: 0.502~0.864, p=0.003]. Subgroup analyses showed a significant association in all models in Asian population, but no significant association in any model in European population. For the XbaI polymorphism, overall, no significant association was observed under any genetic models. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population. The present meta-analysis suggests that ESR1gene PvuII polymorphism is significantly associated with an increased risk of POF. And ESR1gene XbaI polymorphism is not association with risk of POF overall. However, under dominant model, ESR1gene XbaI polymorphism is significantly association with risk of POF in Asian population. Further large and well-designed studies are needed to confirm the association.
Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a (ESR1) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: T.C and XbaI-rs9340799: A.G) and POF.BACKGROUND AND AIMSGenetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a (ESR1) has been suggested as a possible candidate gene for POF; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: T.C and XbaI-rs9340799: A.G) and POF.A comprehensive search was conducted to identify all studies on the association of ESR1 gene polymorphisms with POF up to August 2014. Pooled odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated using fixed-or random-effects model in the meta-analysis.METHODSA comprehensive search was conducted to identify all studies on the association of ESR1 gene polymorphisms with POF up to August 2014. Pooled odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated using fixed-or random-effects model in the meta-analysis.Three studies covering 1396 subjects were identified. Pooled data showed significant association between ESR1 gene PvuII polymorphism and risk of POF: [allele model: Cvs. T, OR = 0.735, 95%CI: 0.624 ~ 0.865, p = 0.001; co-dominant models: CCvs.TT, OR = 0.540, 95%CI: 0.382 ~ 0.764, p = 0.001, CTvs.TT, OR = 0.735, 95%CI: 0.555 ~ 0.972, p = 0.031; dominant model: CT + CCvs.TT, OR = 0.618, 95%CI: 0.396 ~ 0.966, p = 0.035; recessive model: CCvs.TT + CT, OR = 0.659, 95%CI: 0.502 ~ 0.864, p = 0.003]. Subgroup analyses showed a significant association in all models in Asian population, but no significant association in any model in European population. For the XbaI polymorphism, overall, no significant association was observed under any genetic models. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population.RESULTSThree studies covering 1396 subjects were identified. Pooled data showed significant association between ESR1 gene PvuII polymorphism and risk of POF: [allele model: Cvs. T, OR = 0.735, 95%CI: 0.624 ~ 0.865, p = 0.001; co-dominant models: CCvs.TT, OR = 0.540, 95%CI: 0.382 ~ 0.764, p = 0.001, CTvs.TT, OR = 0.735, 95%CI: 0.555 ~ 0.972, p = 0.031; dominant model: CT + CCvs.TT, OR = 0.618, 95%CI: 0.396 ~ 0.966, p = 0.035; recessive model: CCvs.TT + CT, OR = 0.659, 95%CI: 0.502 ~ 0.864, p = 0.003]. Subgroup analyses showed a significant association in all models in Asian population, but no significant association in any model in European population. For the XbaI polymorphism, overall, no significant association was observed under any genetic models. However, under dominant model, ESR1 gene XbaI polymorphism is significantly association with risk of POF in Asian population.The present meta-analysis suggests that ESR1gene PvuII polymorphism is significantly associated with an increased risk of POF. And ESR1gene XbaI polymorphism is not association with risk of POF overall. However, under dominant model, ESR1gene XbaI polymorphism is significantly association with risk of POF in Asian population. Further large and well-designed studies are needed to confirm the association.CONCLUSIONThe present meta-analysis suggests that ESR1gene PvuII polymorphism is significantly associated with an increased risk of POF. And ESR1gene XbaI polymorphism is not association with risk of POF overall. However, under dominant model, ESR1gene XbaI polymorphism is significantly association with risk of POF in Asian population. Further large and well-designed studies are needed to confirm the association.
Author Tang, Hui
Shu, Jingcheng
He, Meirong
Huang, Xing
Author_xml – sequence: 1
  givenname: Meirong
  surname: He
  fullname: He, Meirong
  organization: Department of Obstetrics and Gynecology, First Affiliated Hospital of Guangxi Medical University
– sequence: 2
  givenname: Jingcheng
  surname: Shu
  fullname: Shu, Jingcheng
  organization: Department of Otorhinolaryngology, First Affiliated Hospital of Guangxi Medical University
– sequence: 3
  givenname: Xing
  surname: Huang
  fullname: Huang, Xing
  email: 18376646056@163.com
  organization: Department of Obstetrics and Gynecology, First Affiliated Hospital of Guangxi Medical University
– sequence: 4
  givenname: Hui
  surname: Tang
  fullname: Tang, Hui
  email: 175917736@qq.com
  organization: Department of Obstetrics and Gynecology, First Affiliated Hospital of Guangxi Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25428437$$D View this record in MEDLINE/PubMed
BookMark eNqNUk1vEzEQtVAR_YAfwAVZ4pIclthre9fLASmKSolUCQRF4mY53tnUZdfe2rtB-TH8V5ykRaUSiJM9mvee3sy8U3TkvAOEXlLyhhJSziIlkoqMUJ4RVrFs-wSdUFGyrGSMHKU_ETIjvJDH6DTGG0JIJXP2DB3ngueSs_IE_ZzH6I3Vg_UOr2D4AeAwxCH4dfoEMNAPPmicKsCT8y-f6RR_2ozLJZ5czRZTrF2Nv610KueziynufbvtfOivbezivtkH6PQwBsB-o4PVDjfatrs62Pj9LYaNrcEZwE3wHda4g0Fn2ul2G218jp42uo3w4u49Q1_fn18tPmSXHy-Wi_llZtK0Q5YXHCgF0XDJipxJSnJDDZOFXrGaE0k4sFoKxgyvK1GXBhirCwG77ZUlqdkZenfQ7cdVB7UBNwTdqj7YToet8tqqPzvOXqu13yjOBKcVSwKTO4Hgb8e0P9XZaKBttQM_RkWLQua8IgX9D6iokimRiwR9_Qh648eQdrNHSVYKLnhCvXpo_rfr-yMnQHkAmOBjDNAoY4f9xdMstlWUqF2c1CFOKsVJ7eKktolJHzHvxf_FyQ-cmLBuDeGB6b-SfgG4m9v_
CitedBy_id crossref_primary_10_1097_GRF_0000000000000575
crossref_primary_10_1159_000527271
crossref_primary_10_1155_2021_4862164
crossref_primary_10_18502_ijrm_v20i10_12268
crossref_primary_10_1007_s43032_023_01311_y
crossref_primary_10_1186_s41043_023_00357_7
crossref_primary_10_1038_s41598_022_17383_w
crossref_primary_10_12659_MSM_901247
crossref_primary_10_21518_2079_701X_2020_11_178_185
crossref_primary_10_1007_s10815_018_1357_4
crossref_primary_10_1016_j_ejogrb_2020_07_045
crossref_primary_10_1097_FPC_0000000000000386
crossref_primary_10_1155_2022_8361808
Cites_doi 10.3349/ymj.2004.45.3.479
10.1007/s11033-012-1699-4
10.1093/carcin/21.4.623
10.1136/bmj.315.7109.629
10.1097/01.gco.0000169101.83342.96
10.1016/S0889-8545(03)00027-5
10.1111/j.1365-2265.2007.03073.x
10.1001/jama.292.17.2105
10.1016/j.meegid.2013.08.001
10.3109/09513590.2012.731113
10.1016/S0015-0282(98)00099-5
10.1016/j.ejogrb.2011.06.028
10.1093/humrep/dep375
10.1291/hypres.30.205
10.1124/mi.3.5.281
10.1007/s00404-010-1815-4
10.1093/oxfordjournals.aje.a000179
10.1097/FPC.0b013e328343a132
10.1001/jama.291.24.2969
10.1136/jmg.37.5.e2
10.1186/1746-1596-8-118
10.1111/j.1749-6632.2000.tb06251.x
10.1172/JCI11320
10.3109/13697137.2013.819330
10.1093/hmg/ddg176
10.1097/00001703-199706000-00012
10.1016/S0015-0282(16)47433-9
ContentType Journal Article
Copyright Springer Science+Business Media New York 2014
Springer Science+Business Media New York 2015
Copyright_xml – notice: Springer Science+Business Media New York 2014
– notice: Springer Science+Business Media New York 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOI 10.1007/s10815-014-0393-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts

MEDLINE
ProQuest Central Student
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-7330
EndPage 304
ExternalDocumentID PMC4354193
3605286221
25428437
10_1007_s10815_014_0393_y
Genre Meta-Analysis
Journal Article
Feature
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2WC
2~H
30V
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
AOIJS
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BAWUL
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DIK
DL5
DNIVK
DPUIP
DU5
E3Z
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GX1
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HYE
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LK8
LLZTM
M1P
M4Y
M7P
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OK1
OVD
P19
P2P
P6G
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RNI
ROL
RPM
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
XJT
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FD
8FK
ABRTQ
AZQEC
DWQXO
FR3
GNUQQ
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
ID FETCH-LOGICAL-c573t-264e11e5f4836238102c1c386ab3d40804e3d8533c4d95d7ce33d65e0815770d3
IEDL.DBID U2A
ISSN 1058-0468
1573-7330
IngestDate Thu Aug 21 18:29:41 EDT 2025
Fri Jul 11 08:33:19 EDT 2025
Tue Aug 05 10:25:22 EDT 2025
Fri Jul 25 19:36:15 EDT 2025
Thu Apr 03 06:52:14 EDT 2025
Tue Jul 01 02:01:27 EDT 2025
Thu Apr 24 22:59:14 EDT 2025
Fri Feb 21 02:36:55 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Estrogen receptor alpha gene
Premature ovarian failure
Polymorphism
Meta-analysis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c573t-264e11e5f4836238102c1c386ab3d40804e3d8533c4d95d7ce33d65e0815770d3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://link.springer.com/content/pdf/10.1007/s10815-014-0393-y.pdf
PMID 25428437
PQID 1658375454
PQPubID 37828
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4354193
proquest_miscellaneous_1668249061
proquest_miscellaneous_1659770525
proquest_journals_1658375454
pubmed_primary_25428437
crossref_citationtrail_10_1007_s10815_014_0393_y
crossref_primary_10_1007_s10815_014_0393_y
springer_journals_10_1007_s10815_014_0393_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-02-01
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: 2015-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: Netherlands
– name: New York
PublicationSubtitle Official Publication of ALPHA, Scientists in Reproductive Medicine
PublicationTitle Journal of assisted reproduction and genetics
PublicationTitleAbbrev J Assist Reprod Genet
PublicationTitleAlternate J Assist Reprod Genet
PublicationYear 2015
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Hodgin, Krege, Reddick, Korach, Smithies, Maeda (CR27) 2001; 107
Lorentzon, Lorentzon, Bäckström, Nordström (CR29) 1999; 84
Molvarec, Vér, Fekete, Rosta, Derzbach, Derzsy (CR13) 2007; 30
Lorentzon, Lorentzon, Bäckström, Nordström (CR33) 1999; 84
Romerius, Giwercman, Moëll, Relander, Cavallin-Ståhl, Wiebe (CR26) 2011; 21
Timmreck, Reindollar (CR5) 2003; 30
Du, Xu, Fang, Qi (CR25) 2012; 5
Weiderpass, Persson, Melhus, Wedrén, Kindmark, Baron (CR30) 2000; 21
Christofolini, Vilarino, Mafra, André, Bianco, Barbosa (CR24) 2011; 158
Coulam, Adamson, Annegers (CR3) 1986; 67
Ioannidis, Ralston, Bennett, Brandi, Grinberg, Karassa (CR28) 2004; 292
Gong, Yang, Qi, Shen, Du (CR18) 2013; 20
Matthews, Gustafsson (CR12) 2003; 3
Schuit, Oei, Witteman, van Kessel Geurts, van Meurs, Nijhuis (CR32) 2004; 291
Egger, Davey Smith, Schneider, Minder (CR19) 1997; 315
Conway (CR10) 1997; 9
Yu, Wang, Zhai, Dang, Sun (CR20) 2012; 39
Anasti (CR15) 1998; 70
Rebar (CR8) 1982; 27
Little, Bradley, Bray, Clyne, Dorman, Ellsworth (CR16) 2002; 156
Wang, Teng, Cai, Wang, Zhao, Yu (CR17) 2013; 8
Coulam, Stringfellow, Hoefnagel (CR9) 1983; 40
Liu, Tan, Cui, Liu, Wu (CR21) 2013; 29
Kalantaridou, Nelson (CR2) 2000; 900
van Meurs, Schuit, Weel, van der Klift, Bergink, Arp (CR31) 2003; 12
Kolibianakis, Papanikolaou, Fatemi, Devroey (CR14) 2005; 17
Li, Vujovic, Dalgleish, Thompson, Dragojevic-Dikic, Al-Azzawi (CR22) 2014; 17
Cordts, Christofolini, Dos Santos, Bianco, Barbosa (CR11) 2011; 283
Pelletier, El-Alfy (CR34) 2000; 85
Yoon, Choi, Hong, Lee, Kim, Im (CR23) 2010; 25
Santoro (CR4) 2003; 64
Burton, Van Ee, Purcell, Winship, Shelling (CR1) 2000; 37
Jeong, Cho, Kim, Lee, Cho, Choi (CR6) 2004; 45
Welt (CR7) 2008; 68
CB Coulam (393_CR9) 1983; 40
JB Hodgin (393_CR27) 2001; 107
J Li (393_CR22) 2014; 17
M Egger (393_CR19) 1997; 315
Y Yu (393_CR20) 2012; 39
J Little (393_CR16) 2002; 156
P Romerius (393_CR26) 2011; 21
A Molvarec (393_CR13) 2007; 30
M Lorentzon (393_CR29) 1999; 84
LS Timmreck (393_CR5) 2003; 30
T Gong (393_CR18) 2013; 20
JN Anasti (393_CR15) 1998; 70
J Matthews (393_CR12) 2003; 3
CK Welt (393_CR7) 2008; 68
SH Yoon (393_CR23) 2010; 25
EM Kolibianakis (393_CR14) 2005; 17
JP Ioannidis (393_CR28) 2004; 292
SC Schuit (393_CR32) 2004; 291
RW Rebar (393_CR8) 1982; 27
JB Meurs van (393_CR31) 2003; 12
M Lorentzon (393_CR33) 1999; 84
JW Du (393_CR25) 2012; 5
GS Conway (393_CR10) 1997; 9
HJ Jeong (393_CR6) 2004; 45
L Wang (393_CR17) 2013; 8
CB Coulam (393_CR3) 1986; 67
E Weiderpass (393_CR30) 2000; 21
EB Cordts (393_CR11) 2011; 283
DM Christofolini (393_CR24) 2011; 158
L Liu (393_CR21) 2013; 29
SN Kalantaridou (393_CR2) 2000; 900
N Santoro (393_CR4) 2003; 64
KA Burton (393_CR1) 2000; 37
G Pelletier (393_CR34) 2000; 85
15870558 - Curr Opin Obstet Gynecol. 2005 Jun;17(3):249-53
22108961 - Mol Med Rep. 2012 Feb;5(2):473-6
10753195 - Carcinogenesis. 2000 Apr;21(4):623-7
11160157 - J Clin Invest. 2001 Feb;107(3):333-40
6628716 - Fertil Steril. 1983 Nov;40(5):693-5
9310563 - BMJ. 1997 Sep 13;315(7109):629-34
15523071 - JAMA. 2004 Nov 3;292(17):2105-14
15227735 - Yonsei Med J. 2004 Jun 30;45(3):479-82
9660412 - Fertil Steril. 1998 Jul;70(1):1-15
12773939 - Ann Endocrinol (Paris). 2003 Apr;64(2):87-92
12837697 - Hum Mol Genet. 2003 Jul 15;12(14):1745-54
19861327 - Hum Reprod. 2010 Jan;25(1):283-7
23805834 - Climacteric. 2014 Jun;17(3):247-51
17510501 - Hypertens Res. 2007 Mar;30(3):205-11
3960433 - Obstet Gynecol. 1986 Apr;67(4):604-6
23856170 - Diagn Pathol. 2013;8:118
10818427 - Ann N Y Acad Sci. 2000;900:393-402
21188402 - Arch Gynecol Obstet. 2011 Mar;283(3):635-43
23116284 - Gynecol Endocrinol. 2013 Feb;29(2):182-5
6808131 - J Reprod Med. 1982 Apr;27(4):179-86
10599725 - J Clin Endocrinol Metab. 1999 Dec;84(12):4597-601
17970776 - Clin Endocrinol (Oxf). 2008 Apr;68(4):499-509
22714907 - Mol Biol Rep. 2012 Aug;39(8):8457-63
10807701 - J Med Genet. 2000 May;37(5):E2
11134151 - J Clin Endocrinol Metab. 2000 Dec;85(12):4835-40
12836721 - Obstet Gynecol Clin North Am. 2003 Jun;30(2):287-302
21430602 - Pharmacogenet Genomics. 2011 May;21(5):263-9
14993442 - Mol Interv. 2003 Aug;3(5):281-92
23933403 - Infect Genet Evol. 2013 Dec;20:1-7
15213208 - JAMA. 2004 Jun 23;291(24):2969-77
9263705 - Curr Opin Obstet Gynecol. 1997 Jun;9(3):202-6
12181099 - Am J Epidemiol. 2002 Aug 15;156(4):300-10
21764500 - Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):260-4
References_xml – volume: 45
  start-page: 479
  issue: 3
  year: 2004
  end-page: 82
  ident: CR6
  article-title: G769A variation of inhibin alpha-gene in korean women with premature ovarian failure
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2004.45.3.479
– volume: 39
  start-page: 8457
  issue: 8
  year: 2012
  end-page: 63
  ident: CR20
  article-title: IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-012-1699-4
– volume: 5
  start-page: 473
  issue: 2
  year: 2012
  end-page: 6
  ident: CR25
  article-title: Association between mutations of the luteinizing hormone β subunit and female infertility
  publication-title: Mol Med Rep
– volume: 84
  start-page: 4597
  issue: 12
  year: 1999
  end-page: 601
  ident: CR33
  article-title: Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross-sectional and longitudinal study
  publication-title: J Clin Endocrinol Metab
– volume: 21
  start-page: 623
  issue: 4
  year: 2000
  end-page: 7
  ident: CR30
  article-title: Estrogen receptor alpha gene polymorphisms and endometrial cancer risk
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/21.4.623
– volume: 315
  start-page: 629
  issue: 7109
  year: 1997
  end-page: 34
  ident: CR19
  article-title: Bias in meta-analysis detected by a simple, graphical test
  publication-title: BMJ
  doi: 10.1136/bmj.315.7109.629
– volume: 84
  start-page: 4597
  issue: 12
  year: 1999
  end-page: 601
  ident: CR29
  article-title: Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross-sectional and longitudinal study
  publication-title: J Clin Endocrinol Metab
– volume: 17
  start-page: 249
  issue: 3
  year: 2005
  end-page: 53
  ident: CR14
  article-title: Estrogen and folliculogenesis: is one necessary for the other?
  publication-title: Curr Opin Obstet Gynecol
  doi: 10.1097/01.gco.0000169101.83342.96
– volume: 30
  start-page: 287
  issue: 2
  year: 2003
  end-page: 302
  ident: CR5
  article-title: Contemporary issues in primary amenorrhea
  publication-title: Obstet Gynecol Clin N Am
  doi: 10.1016/S0889-8545(03)00027-5
– volume: 68
  start-page: 499
  issue: 4
  year: 2008
  end-page: 509
  ident: CR7
  article-title: Primary ovarian insufficiency: a more accurate term for premature ovarian failure
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2007.03073.x
– volume: 292
  start-page: 2105
  issue: 17
  year: 2004
  end-page: 14
  ident: CR28
  article-title: GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes
  publication-title: JAMA
  doi: 10.1001/jama.292.17.2105
– volume: 85
  start-page: 4835
  issue: 12
  year: 2000
  end-page: 40
  ident: CR34
  article-title: Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs
  publication-title: J Clin Endocrinol Metab
– volume: 20
  start-page: 1
  year: 2013
  end-page: 7
  ident: CR18
  article-title: Association of MCP-1–2518A/G and -362G/C variants and tuberculosis susceptibility: a meta-analysis
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2013.08.001
– volume: 29
  start-page: 182
  issue: 2
  year: 2013
  end-page: 5
  ident: CR21
  article-title: Estrogen receptor α gene (ESR1) polymorphisms associated with idiopathic premature ovarian failure in Chinese women
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2012.731113
– volume: 70
  start-page: 1
  issue: 1
  year: 1998
  end-page: 15
  ident: CR15
  article-title: Premature ovarian failure: an update
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(98)00099-5
– volume: 158
  start-page: 260
  issue: 2
  year: 2011
  end-page: 4
  ident: CR24
  article-title: Combination of polymorphisms in luteinizing hormone β, estrogen receptor β and progesterone receptor and susceptibility to infertility and endometriosis
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2011.06.028
– volume: 25
  start-page: 283
  issue: 1
  year: 2010
  end-page: 7
  ident: CR23
  article-title: Estrogen receptor {alpha} gene polymorphisms in patients with idiopathic premature ovarian failure
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dep375
– volume: 30
  start-page: 205
  issue: 3
  year: 2007
  end-page: 11
  ident: CR13
  article-title: Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia
  publication-title: Hypertens Res
  doi: 10.1291/hypres.30.205
– volume: 40
  start-page: 693
  issue: 5
  year: 1983
  end-page: 5
  ident: CR9
  article-title: Evidence for a genetic factor in the etiology of premature ovarian failure
  publication-title: Fertil Steril
– volume: 64
  start-page: 87
  issue: 2
  year: 2003
  end-page: 92
  ident: CR4
  article-title: Mechanisms of premature ovarian failure
  publication-title: Ann Endocrinol (Paris)
– volume: 3
  start-page: 281
  issue: 5
  year: 2003
  end-page: 92
  ident: CR12
  article-title: Estrogen signaling: a subtle balance between ER alpha and ER beta
  publication-title: Mol Interv
  doi: 10.1124/mi.3.5.281
– volume: 67
  start-page: 604
  issue: 4
  year: 1986
  end-page: 6
  ident: CR3
  article-title: Incidence of premature ovarian failure
  publication-title: Obstet Gynecol
– volume: 283
  start-page: 635
  issue: 3
  year: 2011
  end-page: 43
  ident: CR11
  article-title: Genetic aspects of premature ovarian failure: a literature review
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-010-1815-4
– volume: 27
  start-page: 179
  issue: 4
  year: 1982
  end-page: 86
  ident: CR8
  article-title: Hypergonadotropic amenorrhea and premature ovarian failure: a review
  publication-title: J Reprod Med
– volume: 156
  start-page: 300
  issue: 4
  year: 2002
  end-page: 10
  ident: CR16
  article-title: Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a000179
– volume: 21
  start-page: 263
  issue: 5
  year: 2011
  end-page: 9
  ident: CR26
  article-title: Estrogen receptor α single nucleotide polymorphism modifies the risk of azoospermia in childhood cancer survivors
  publication-title: Pharmacogenet Genomics
  doi: 10.1097/FPC.0b013e328343a132
– volume: 291
  start-page: 2969
  issue: 24
  year: 2004
  end-page: 77
  ident: CR32
  article-title: Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction
  publication-title: JAMA
  doi: 10.1001/jama.291.24.2969
– volume: 37
  start-page: E2
  issue: 5
  year: 2000
  ident: CR1
  article-title: Autosomal translocation associated with premature ovarian failure
  publication-title: J Med Genet
  doi: 10.1136/jmg.37.5.e2
– volume: 8
  start-page: 118
  year: 2013
  ident: CR17
  article-title: The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects
  publication-title: Diagn Pathol
  doi: 10.1186/1746-1596-8-118
– volume: 900
  start-page: 393
  year: 2000
  end-page: 402
  ident: CR2
  article-title: Premature ovarian failure is not premature menopause
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2000.tb06251.x
– volume: 107
  start-page: 333
  issue: 3
  year: 2001
  end-page: 40
  ident: CR27
  article-title: Estrogen receptor alpha is a major mediator of 17beta-estradiol’s atheroprotective effects on lesion size in Apoe−/− mice
  publication-title: J Clin Invest
  doi: 10.1172/JCI11320
– volume: 17
  start-page: 247
  issue: 3
  year: 2014
  end-page: 51
  ident: CR22
  article-title: Lack of association between ESR1 gene polymorphisms and premature ovarian failure in Serbian women
  publication-title: Climacteric
  doi: 10.3109/13697137.2013.819330
– volume: 12
  start-page: 1745
  issue: 14
  year: 2003
  end-page: 54
  ident: CR31
  article-title: Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddg176
– volume: 9
  start-page: 202
  issue: 3
  year: 1997
  end-page: 6
  ident: CR10
  article-title: Premature ovarian failure
  publication-title: Curr Opin Obstet Gynecol
  doi: 10.1097/00001703-199706000-00012
– volume: 84
  start-page: 4597
  issue: 12
  year: 1999
  ident: 393_CR29
  publication-title: J Clin Endocrinol Metab
– volume: 37
  start-page: E2
  issue: 5
  year: 2000
  ident: 393_CR1
  publication-title: J Med Genet
  doi: 10.1136/jmg.37.5.e2
– volume: 30
  start-page: 205
  issue: 3
  year: 2007
  ident: 393_CR13
  publication-title: Hypertens Res
  doi: 10.1291/hypres.30.205
– volume: 40
  start-page: 693
  issue: 5
  year: 1983
  ident: 393_CR9
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(16)47433-9
– volume: 25
  start-page: 283
  issue: 1
  year: 2010
  ident: 393_CR23
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dep375
– volume: 283
  start-page: 635
  issue: 3
  year: 2011
  ident: 393_CR11
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-010-1815-4
– volume: 291
  start-page: 2969
  issue: 24
  year: 2004
  ident: 393_CR32
  publication-title: JAMA
  doi: 10.1001/jama.291.24.2969
– volume: 5
  start-page: 473
  issue: 2
  year: 2012
  ident: 393_CR25
  publication-title: Mol Med Rep
– volume: 900
  start-page: 393
  year: 2000
  ident: 393_CR2
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2000.tb06251.x
– volume: 156
  start-page: 300
  issue: 4
  year: 2002
  ident: 393_CR16
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a000179
– volume: 315
  start-page: 629
  issue: 7109
  year: 1997
  ident: 393_CR19
  publication-title: BMJ
  doi: 10.1136/bmj.315.7109.629
– volume: 29
  start-page: 182
  issue: 2
  year: 2013
  ident: 393_CR21
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2012.731113
– volume: 3
  start-page: 281
  issue: 5
  year: 2003
  ident: 393_CR12
  publication-title: Mol Interv
  doi: 10.1124/mi.3.5.281
– volume: 9
  start-page: 202
  issue: 3
  year: 1997
  ident: 393_CR10
  publication-title: Curr Opin Obstet Gynecol
  doi: 10.1097/00001703-199706000-00012
– volume: 8
  start-page: 118
  year: 2013
  ident: 393_CR17
  publication-title: Diagn Pathol
  doi: 10.1186/1746-1596-8-118
– volume: 27
  start-page: 179
  issue: 4
  year: 1982
  ident: 393_CR8
  publication-title: J Reprod Med
– volume: 85
  start-page: 4835
  issue: 12
  year: 2000
  ident: 393_CR34
  publication-title: J Clin Endocrinol Metab
– volume: 67
  start-page: 604
  issue: 4
  year: 1986
  ident: 393_CR3
  publication-title: Obstet Gynecol
– volume: 17
  start-page: 249
  issue: 3
  year: 2005
  ident: 393_CR14
  publication-title: Curr Opin Obstet Gynecol
  doi: 10.1097/01.gco.0000169101.83342.96
– volume: 21
  start-page: 263
  issue: 5
  year: 2011
  ident: 393_CR26
  publication-title: Pharmacogenet Genomics
  doi: 10.1097/FPC.0b013e328343a132
– volume: 39
  start-page: 8457
  issue: 8
  year: 2012
  ident: 393_CR20
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-012-1699-4
– volume: 64
  start-page: 87
  issue: 2
  year: 2003
  ident: 393_CR4
  publication-title: Ann Endocrinol (Paris)
– volume: 68
  start-page: 499
  issue: 4
  year: 2008
  ident: 393_CR7
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2007.03073.x
– volume: 20
  start-page: 1
  year: 2013
  ident: 393_CR18
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2013.08.001
– volume: 292
  start-page: 2105
  issue: 17
  year: 2004
  ident: 393_CR28
  publication-title: JAMA
  doi: 10.1001/jama.292.17.2105
– volume: 84
  start-page: 4597
  issue: 12
  year: 1999
  ident: 393_CR33
  publication-title: J Clin Endocrinol Metab
– volume: 30
  start-page: 287
  issue: 2
  year: 2003
  ident: 393_CR5
  publication-title: Obstet Gynecol Clin N Am
  doi: 10.1016/S0889-8545(03)00027-5
– volume: 45
  start-page: 479
  issue: 3
  year: 2004
  ident: 393_CR6
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2004.45.3.479
– volume: 158
  start-page: 260
  issue: 2
  year: 2011
  ident: 393_CR24
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2011.06.028
– volume: 70
  start-page: 1
  issue: 1
  year: 1998
  ident: 393_CR15
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(98)00099-5
– volume: 107
  start-page: 333
  issue: 3
  year: 2001
  ident: 393_CR27
  publication-title: J Clin Invest
  doi: 10.1172/JCI11320
– volume: 12
  start-page: 1745
  issue: 14
  year: 2003
  ident: 393_CR31
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddg176
– volume: 17
  start-page: 247
  issue: 3
  year: 2014
  ident: 393_CR22
  publication-title: Climacteric
  doi: 10.3109/13697137.2013.819330
– volume: 21
  start-page: 623
  issue: 4
  year: 2000
  ident: 393_CR30
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/21.4.623
– reference: 15227735 - Yonsei Med J. 2004 Jun 30;45(3):479-82
– reference: 21188402 - Arch Gynecol Obstet. 2011 Mar;283(3):635-43
– reference: 17970776 - Clin Endocrinol (Oxf). 2008 Apr;68(4):499-509
– reference: 12181099 - Am J Epidemiol. 2002 Aug 15;156(4):300-10
– reference: 23856170 - Diagn Pathol. 2013;8:118
– reference: 23933403 - Infect Genet Evol. 2013 Dec;20:1-7
– reference: 22714907 - Mol Biol Rep. 2012 Aug;39(8):8457-63
– reference: 12837697 - Hum Mol Genet. 2003 Jul 15;12(14):1745-54
– reference: 9310563 - BMJ. 1997 Sep 13;315(7109):629-34
– reference: 11160157 - J Clin Invest. 2001 Feb;107(3):333-40
– reference: 15213208 - JAMA. 2004 Jun 23;291(24):2969-77
– reference: 15523071 - JAMA. 2004 Nov 3;292(17):2105-14
– reference: 21430602 - Pharmacogenet Genomics. 2011 May;21(5):263-9
– reference: 23116284 - Gynecol Endocrinol. 2013 Feb;29(2):182-5
– reference: 10753195 - Carcinogenesis. 2000 Apr;21(4):623-7
– reference: 10807701 - J Med Genet. 2000 May;37(5):E2
– reference: 15870558 - Curr Opin Obstet Gynecol. 2005 Jun;17(3):249-53
– reference: 23805834 - Climacteric. 2014 Jun;17(3):247-51
– reference: 9263705 - Curr Opin Obstet Gynecol. 1997 Jun;9(3):202-6
– reference: 22108961 - Mol Med Rep. 2012 Feb;5(2):473-6
– reference: 12836721 - Obstet Gynecol Clin North Am. 2003 Jun;30(2):287-302
– reference: 9660412 - Fertil Steril. 1998 Jul;70(1):1-15
– reference: 14993442 - Mol Interv. 2003 Aug;3(5):281-92
– reference: 10599725 - J Clin Endocrinol Metab. 1999 Dec;84(12):4597-601
– reference: 10818427 - Ann N Y Acad Sci. 2000;900:393-402
– reference: 21764500 - Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):260-4
– reference: 3960433 - Obstet Gynecol. 1986 Apr;67(4):604-6
– reference: 6808131 - J Reprod Med. 1982 Apr;27(4):179-86
– reference: 12773939 - Ann Endocrinol (Paris). 2003 Apr;64(2):87-92
– reference: 19861327 - Hum Reprod. 2010 Jan;25(1):283-7
– reference: 11134151 - J Clin Endocrinol Metab. 2000 Dec;85(12):4835-40
– reference: 6628716 - Fertil Steril. 1983 Nov;40(5):693-5
– reference: 17510501 - Hypertens Res. 2007 Mar;30(3):205-11
SSID ssj0009823
Score 2.1414752
SecondaryResourceType review_article
Snippet Background and aims Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a ( ESR1 ) has been...
Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a (ESR1) has been suggested as a possible...
Background and aims: Genetic factors are important in the pathogenesis of Premature ovarian failure (POF). Notably, estrogen receptor-a (ESR1) has been...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 297
SubjectTerms Amenorrhea
Asian Continental Ancestry Group - genetics
Asian people
Confidence intervals
Deoxyribonucleases, Type II Site-Specific - genetics
Deoxyribonucleases, Type II Site-Specific - metabolism
DNA-Cytosine Methylases - genetics
DNA-Cytosine Methylases - metabolism
Estrogen Receptor alpha - genetics
Estrogens
Female
Genetic Predisposition to Disease
Genetics
Gynecology
Human Genetics
Humans
Infertility
Medicine
Medicine & Public Health
Meta-analysis
Otolaryngology
Ovaries
Polymorphism
Polymorphism, Single Nucleotide
Primary Ovarian Insufficiency - genetics
Reproductive Medicine
Womens health
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgSIgXxG8CAx0SDyvIahPbscsLmqaNDQmEYJP6Fjmxo1Vak9Afk_rH8L9yl7jtykTfGtlJk9zZ9zn3-TvG3ktVDkTiPLcmFVxKnXLjk5LnGMtFOUxs6VuW7_f09EJ-HalR-OA2C7TK1ZzYTtSuLugbeT_GUEnlWpX83PzmVDWKsquhhMZddo-ky4jSpUd6I7prko5grwxRGM0qq9ltnTMx0dYkp92pfLkdl26BzducyX8Sp208OnnEHgYgCYed5R-zO756wu5_C6nyp-zPjRcPgY0F-F_TGl0GcJ7zDS63LeCRh4PjXz_jHvy4XpydwcF5_6gHtnIwyi0eHva_9KCpr5aTGo0ynk1mbWMzJbnXxdRDfY0LbltBacdEcgeiq38CH-qVAu1gAQsTP7fcBg2UZ-zi5Pj86JSHWgy8UFrMiQjn49irUhoMeSQLlhRxIUxqc-Ekwk7phcPQLwrphsrpwgvhUuXpLWs9cOI526vqyr9kUA4HLo9Lo02eyyKm36pQSatRarVNIzZYWSIrglA51cu4yjYSy3TZDI2XkfGyZcQ-rE9pOpWOXZ33V-bNwoCdZRv3iti7dTMONcqf2MrXi7YPomUq_LerT2pwRYsoKWIvOo9Z3xGuxREMCB0xveVL6w4k9b3dUo0vW8lvBLUSoXbEPq687sat_-9BX-1-0NfsAaI_1VHQ99nefLrwbxBhzfO37TD6C0PwIbw
  priority: 102
  providerName: ProQuest
Title Association between estrogen receptora gene (ESR1) PvuII (T/C) and XbaI (A/G) polymorphisms and premature ovarian failure risk: evidence from a meta-analysis
URI https://link.springer.com/article/10.1007/s10815-014-0393-y
https://www.ncbi.nlm.nih.gov/pubmed/25428437
https://www.proquest.com/docview/1658375454
https://www.proquest.com/docview/1659770525
https://www.proquest.com/docview/1668249061
https://pubmed.ncbi.nlm.nih.gov/PMC4354193
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEB7ygNJLadNH1KZhCz3ELSKWdle77s0xjpOWhpDGoJ7ESlpRQywZPwL-Mf2vndHDsZM20ItlaceypJnVfMN8OwPwUciszf3UukYH3BVCBa62fubG6Mt51vFNZkuW70VwNhRfQxnW67hnDdu9SUmWb-q1xW7aI6KZcGk9qbvchl1JoTsa8dDv3lXa1X7FqpeaeIu6SWX-7RSbzugBwnxIlLyXLS2d0OlzeFajR9at1P0Ctmy-B0--1_nxl_B77WmzmoLF8L-mBdoJw5ebnWCMbRjuWXbU_3Hltdjl7eL8nB1dH_dazOQpC2ODu93jQYtNipvluEBNjGbjWTk4mVKN18XUsuIWo2yTs8yMiNnOiKP-hdm6SSmjZSvMsLGdG9fUhU9ewfC0f907c-sGDG4iFZ8T-816npWZ0OjnqBaYn3gJ14GJeSoQawrLU_T3PBFpR6YqsZyngbT0lJVqp_w17ORFbveBZZ12GnuZVjqOReLRd5mg-qgwqVEmcKDdaCJK6urk1CTjJrqrq0ynjVB5ESkvWjrwafWTSVWa4zHhg0a9UT1LZ5GH8ItaAEvhwIfVMM4vSpqY3BaLUgYhMnX7e0wm0BjGIjRy4E1lMasrwgAcEQBXDqgNW1oJUH3vzZF89Kus841IViC-duBzY3Vrl_6vG337X9Lv4CkiQFnR0A9gZz5d2PeIsubxIWyrUOGn7nmHsNsd_PzWx-1J_-LyCo8OQjxK8-4Px7Akhg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwED6NTgK-IN4JDDASSCvIahPbiYuE0BgdLduqaXRSvwUndkSlNSl9GeqP4S_wGznnpV2Z6Ld9a2THTXTnu-dy5-cAXnORNJmnDVXSZ5TzwKfSeAmN0JezpOWpxORVvj2_c8a_DsRgC_5UZ2FsWWVlE3NDrbPYfiNvuOgqbbtWwT-Of1LbNcpmV6sWGoVaHJrFLwzZph-6n1G-bzzvoN3f79CyqwCNRcBmtqTLuK4RCZdovC3BlRe7MZO-ipjmCKC4YRqdGIu5bgkdxIYx7QuDvlMEQVMzXPcGbHOGoUwNtj-1eyenK5pf6RUl_ULaoklZ5VGLw3q4AobunNrzsHSx7gmvwNurVZr_pGpzD3hwF-6U0JXsFbp2D7ZMeh9uHpfJ-Qfw-5KoSVn_RfC_JhkqKUHLasYY4CuCV4bstr-dunVycjHvdsluv7FfJyrVZBApvNxrfKmTcXa-GGWoBsPpaJoPjieWYHY-MSS7wBBfpSRRQ1tWT2yB_Htiyg6pxJ6ZIYqMzExRVbKuPISza5HTI6ilWWqeAElaTR25iQxkFPHYtb9FLLycFVUFynegWUkijEtqdNuh4zxckTrbZUMUXmiFFy4ceLu8ZVzwgmyavFOJNyxNxDRcKbQDr5bDuLltxkalJpvncxCf21aDm-b4EmNoxGUOPC40ZvlEGP0j_GCBA8GaLi0nWHLx9ZF0-CMnGUcYzRHcO_Cu0rpLj_6_F326-UVfwq1O__goPOr2Dp_BbcSeoiiA34HabDI3zxHfzaIX5aYi8P269_FfVdBdew
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bbtNAEB1BkSpeEJSbodBF4qEBWYm9u_aGt6htaLhUFTRS3qy1dy0iNbaVOJXyMfwrM76kSQuVeLO1E9vxzHrOas6eAXgvZNrjvrGuVgF3hQgDV1k_dWPM5Tzt-zq1Fcv3LDgdiy8TOWn6nC5atntbkqz3NJBKU1Z2C5N2Nza-KY9IZ8KlvaXu6j48wK-xR2E99gfXqrvKrxn2UhGHUbVlzb9dYjsx3UKbt0mTNyqnVUIaPoZHDZJkg9r1T-CezfZg93tTK38KvzfePGvoWAzvNc8xZhh-6GyB623N8Myyw5OfP7wOO79ajkbs8KJ71GE6M2wSazwddD93WJFfrmY5emW6mC2qwWJOeq_LuWX5Fa64dcZSPSWWOyO--idmm4aljLawMM1mttSubkRQnsF4eHJxdOo2zRjcRIa8JCac9TwrU6Ew55EumJ94CVeBjrkRiDuF5QZzP0-E6UsTJpZzE0hLbzkMe4Y_h50sz-xLYGm_Z2IvVaGKY5F4dCwT6VcipTrUgQO91hNR0iiVU8OMy-haY5kuG6HzInJetHLgw_onRS3TcZfxfuveqJmxi8hDKEbtgKVw4N16GOcaFVB0ZvNlZYNwmTr_3WUTKFzSIkxy4EUdMesnwsU4ogEeOhBuxdLagLS-t0ey6a9K8xtRrUCs7cDHNuo2Hv1ff_TVf1kfwO758TD6Njr7-hoeIjCUNTt9H3bK-dK-QfBVxm-rCfYHQ5sl4g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+estrogen+receptora+gene+%28ESR1%29+PvuII+%28T%2FC%29+and+XbaI+%28A%2FG%29+polymorphisms+and+premature+ovarian+failure+risk%3A+evidence+from+a+meta-analysis&rft.jtitle=Journal+of+assisted+reproduction+and+genetics&rft.au=He%2C+Meirong&rft.au=Shu%2C+Jingcheng&rft.au=Huang%2C+Xing&rft.au=Tang%2C+Hui&rft.date=2015-02-01&rft.eissn=1573-7330&rft.volume=32&rft.issue=2&rft.spage=297&rft_id=info:doi/10.1007%2Fs10815-014-0393-y&rft_id=info%3Apmid%2F25428437&rft.externalDocID=25428437
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-0468&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-0468&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-0468&client=summon